Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
No trials found
News
NICE Recommends Pedmarqsi as First NHS Treatment for Cisplatin-Induced Hearing Loss in Children
The National Institute for Health and Care Excellence (NICE) has recommended Pedmarqsi for preventing cisplatin-induced hearing loss in young patients aged 1 month to 17 years.